recognit
molecular
divers
cell
surfac
proteom
diseas
essenti
develop
target
therapi
progress
target
therapeut
requir
establish
effect
approach
highthroughput
identif
agent
specif
clinic
relev
cell
surfac
marker
past
decad
number
platform
strategi
develop
screen
polypeptid
librari
ligand
target
receptor
select
express
context
variou
cell
surfac
proteom
streamlin
procedur
identif
ligandreceptor
pair
could
serv
target
diseas
diagnosi
profil
imag
therapi
reli
display
technolog
polypeptid
desir
bind
profil
serial
select
process
call
biopan
base
physic
linkag
encod
nucleic
acid
technolog
includ
virusphag
display
cell
display
ribosom
display
mrna
display
coval
dna
display
cdt
phage
display
far
util
scope
review
recent
advanc
display
technolog
particular
emphasi
molecular
map
cell
surfac
proteom
peptid
phage
display
prospect
applic
target
compound
deriv
display
librari
discoveri
target
drug
gene
therapi
vector
discuss
strategi
identif
druggabl
diseas
marker
develop
approach
liganddirect
target
requir
drug
design
first
part
review
discuss
develop
display
technolog
highthroughput
identif
agent
target
cell
surfac
receptor
second
part
includ
brief
overview
librari
display
scaffold
use
ligand
select
clinic
use
ligand
particular
emphasi
phage
peptid
display
final
address
current
applic
individu
display
technolog
emerg
field
defin
targetom
human
diseas
often
caus
andor
associ
alter
protein
express
evid
subjectspecif
heterogen
protein
express
profil
abnorm
illustr
need
methodolog
profil
individu
patient
diseas
marker
toward
person
treatment
identif
reliabl
diseas
marker
may
enabl
design
target
therapi
well
approach
predict
clinic
behavior
affect
tissu
patholog
indistinguish
perhap
biolog
divers
heterogen
patient
popul
issu
particularli
import
consid
malign
diseas
recent
approach
cancer
biomedicin
reli
empir
tissu
cultur
anim
model
lack
valid
molecular
profil
indic
aggress
cancer
phenotyp
absenc
valid
intermedi
endpoint
made
tumor
difficult
diagnos
manag
despit
occasion
avail
serum
marker
along
patholog
grade
clinic
stage
without
reliabl
way
forecast
tumor
progress
mani
case
cancer
treat
aggress
chanc
cure
often
price
potenti
sever
treatmentassoci
toxic
clear
need
identif
improv
biomark
tumor
progress
metastasi
potenti
mechan
cancer
character
molecular
divers
cancer
essenti
develop
target
therapi
ultim
may
possibl
person
guid
imag
therapeut
compound
tumor
vascular
target
cancer
patient
earli
identif
target
optim
regimen
tailor
molecular
profil
individu
cancer
patient
identif
new
cancerrel
address
may
also
result
revisit
salvag
drug
candid
ineffect
toxic
studi
cancer
recent
yield
broad
rang
molecular
target
upregul
surfac
tumor
tumorassoci
cell
numer
marker
identifi
character
tumor
cell
surround
stroma
tumor
endothelium
analysi
cell
line
panel
includ
carcinoma
sever
origin
kidney
breast
colon
lung
prostat
ovarian
tumor
central
nervou
system
malign
melanoma
leukemia
lymphoma
serv
illustr
marker
heterogen
tumor
cell
parallel
gene
protein
express
analysi
pharmacolog
sensit
cell
differ
chemic
compound
regist
inde
gene
correl
express
data
drug
sensit
profil
uncov
mechanist
basi
activ
certain
drug
thu
convent
genom
proteom
approach
alreadi
identifi
sever
potenti
tumor
marker
drug
target
howev
despit
advanc
correl
drug
activ
gene
express
profil
yet
establish
compound
test
may
suggest
exist
unknown
factor
need
develop
altern
methodolog
discov
druggabl
molecular
target
past
decad
drug
develop
larg
focus
approach
select
deliv
reagent
cell
primarili
respons
affect
diseas
character
molecular
divers
diseas
cell
surfac
level
repres
membraneassoci
protein
often
modifi
lipid
carbohydr
basi
develop
target
therapi
propos
select
express
diseasespecif
receptor
correspond
ligand
appli
toward
develop
system
targetdirect
deliveri
imag
agent
gene
therapi
vector
cytotox
drug
natur
artifici
ligand
bind
surfac
receptor
preferenti
express
access
cell
may
use
direct
therapeut
site
diseas
potenti
increas
therapeut
window
gener
tumor
marker
expos
circul
like
found
endotheli
blood
vesselform
cell
coupl
tissuehom
compound
drug
yield
target
therapeut
like
effect
less
toxic
parent
drug
far
molecul
select
base
home
tumor
use
carrier
guid
deliveri
cytotox
drug
proapoptot
cytotox
peptid
metalloproteas
inhibitor
cytokin
imag
agent
gene
transgen
xenograft
mous
model
human
diseas
proven
feasibl
targetdirect
therapeut
approach
improv
treatment
efficaci
variou
diseas
limit
system
exposur
tissu
untoward
effect
genom
project
led
identif
larg
catalog
human
gene
technolog
advanc
identifi
gene
express
cancer
diseas
use
nucleic
acid
array
serial
analysi
mrna
express
sage
diseas
tissu
sampl
gene
express
determin
highthroughput
microarray
analysi
use
survey
variat
abund
mani
thousand
distinct
transcript
tumor
cell
panel
data
provid
function
insight
correspond
gene
product
malign
tumor
cell
transform
informationintens
genom
approach
yield
candid
tumor
marker
valid
protein
level
prospect
studi
standpoint
system
drug
target
differenti
express
vascular
receptor
anoth
initi
identif
gene
differenti
express
neoplast
normalendothelium
proteom
aim
systemat
analysi
protein
content
individu
cell
tissu
biolog
sampl
use
profil
spectrum
proteom
diseas
proteom
approach
base
twodimension
polyacrylamid
gel
electrophoresi
serv
identif
character
tissuespecif
diseasespecif
protein
elucid
function
role
protein
microarray
also
evolv
allow
fast
highthroughput
profil
protein
constitut
biolog
sampl
although
technolog
still
challeng
technic
constraint
ultim
abil
perform
highthroughput
profil
protein
express
may
lead
construct
proteom
everi
tissu
normal
state
diseas
larg
initi
systemat
regist
protein
complex
form
insid
cell
recent
streamlin
establish
thousand
candid
physiolog
proteinprotein
interact
variou
assay
yeast
twohybrid
system
major
contributor
protein
interact
map
construct
interactom
oper
within
context
cell
surfac
help
identifi
ligandreceptor
system
purpos
therapi
target
technolog
relat
proteom
advanc
new
approach
systemat
molecular
analysi
endothelium
protein
level
also
surfac
howev
convent
method
systemat
protein
express
interact
analysi
may
well
overlook
potenti
diagnost
marker
target
mere
establish
protein
interact
present
tissu
necessarili
take
anatom
context
account
diseas
marker
may
expos
restrict
locat
way
make
good
drug
target
irrespect
express
level
therefor
gener
map
druggabl
receptor
diseasedirect
target
inform
deriv
convent
protein
profil
bind
assess
enhanc
integr
data
function
screen
circulationaccess
molecul
studi
group
other
advanc
concept
vascular
proteom
defin
molecular
phenotyp
cell
form
blood
vessel
proteinprotein
interact
level
tissuespecif
select
express
endotheli
surfac
molecul
uncov
diseas
normal
develop
systemat
profil
select
express
vascular
address
reveal
molecular
target
may
use
direct
therapi
specif
tissu
long
term
continu
attempt
explor
endotheli
molecular
divers
lead
construct
function
ligandreceptor
vascular
map
everi
tissu
method
timeeffici
probe
human
vascular
bed
differenti
express
vascular
cell
surfac
marker
make
possibl
person
vasculartarget
therapi
patient
knowledg
relev
ligandreceptor
interact
deriv
display
technolog
screen
may
becom
use
design
chemic
synthes
peptidomimet
drug
lead
smith
et
al
first
use
librari
display
short
peptid
antibodi
purpos
map
antibodi
epitop
phage
display
see
section
sinc
random
linear
cyclic
peptid
librari
antigenor
genefrag
librari
combin
use
epitop
map
monoclon
antibodi
mab
combinatori
peptid
librari
construct
contain
billion
uniqu
peptid
sequenc
use
sourc
molecul
differ
bind
potenti
strategi
flexibl
constrain
random
peptid
librari
construct
screen
approach
extens
discuss
elsewher
combinatori
peptid
librari
compris
either
complet
random
peptid
backbon
random
defin
posit
serv
identifi
protein
bind
site
excel
review
summar
experi
use
random
semirandom
peptid
librari
context
variou
display
platform
among
commonli
use
librari
gener
structur
cx
n
c
express
random
amino
acid
residuelong
peptid
flank
cycliz
cystein
side
librari
express
cyclic
peptid
filament
phage
surfac
use
group
group
also
use
similar
librari
display
lytic
phage
surfac
evidenc
numer
studi
within
past
decad
cell
surfac
receptor
proteom
map
screen
peptid
librari
discuss
detail
section
peptid
librari
also
select
motif
mimick
epitop
antibodi
produc
diseas
exampl
mintz
et
al
pan
librari
display
random
peptid
autoantibodi
prostat
cancer
patient
led
identif
antigen
overexpress
human
prostat
cancer
anoth
studi
vidal
et
al
found
peptid
human
ovarian
cancer
antigen
epitop
map
pool
antibodi
ascit
purifi
ovarian
cancer
patient
togeth
seem
theme
emerg
stressrespons
chaperon
becom
immunogen
cancer
importantli
peptid
ligand
select
unbias
screen
without
predetermin
notion
natur
cellular
receptor
repertoir
use
subsequ
identif
correspond
target
cell
surfac
receptor
discuss
peptid
target
specif
receptor
surfac
cell
implic
diseas
also
use
direct
imag
agent
cytotox
gene
deliveri
vector
artifici
inhibitori
peptid
produc
transgen
also
use
disrupt
signal
intracellular
pathway
interest
drosophila
model
futur
artifici
gene
product
could
develop
vector
diagnost
therapeut
intent
peptid
may
desir
benefit
current
use
antibodi
increas
tissu
penetr
diffus
rapid
blood
clearanc
simplic
synthesi
vitro
qualiti
control
serendipit
observ
cell
surfacebind
peptid
select
display
librari
often
similar
domain
found
natur
express
protein
exampl
peptid
may
mimic
ligand
vascular
receptor
via
motif
suffici
receptor
recognit
initi
koivunen
et
al
isol
peptid
target
alpha
beta
integrin
via
mimick
fibronectin
peptid
target
alpha
v
beta
alpha
v
beta
integrin
mimick
vitronectin
peptid
target
alpha
iib
beta
integrin
mimick
fibrinogen
major
integrinbind
peptid
contain
three
amino
acid
long
tripeptid
motif
arginineglycineaspart
acid
rgd
base
observ
propos
proven
mani
case
bind
peptid
motif
mimic
interact
cell
surfac
receptor
natur
ligand
exampl
biochem
unit
recognit
bind
ligand
motif
base
rgdintegrin
includ
asparagineglycineaspart
acid
ngr
bind
aminopeptidas
glycinephenylalanineglutam
acid
gfe
membran
dipeptidas
aspart
acidprolineleucin
rpl
thu
stretch
three
residu
appear
provid
minim
framework
structur
format
proteinprotein
interact
discuss
section
group
develop
bioinformat
platform
base
analysi
frequenc
tripeptid
motif
within
peptid
select
screen
identif
prototyp
receptor
ligand
mimick
short
peptid
number
comprehens
review
summar
peptid
motif
correspond
ligand
receptor
system
identifi
use
phage
display
interrog
earli
atherosclerot
lesion
explor
plaqueassoci
endotheli
cell
proteom
kelli
et
al
recent
screen
phagedisplay
random
peptid
librari
apoemic
identifi
plaquetarget
peptid
similar
sever
protein
involv
atherosclerosi
find
may
translat
agent
use
earli
diseas
detect
prospect
applic
specif
small
peptid
specif
need
experiment
target
therapi
critic
evalu
past
year
librari
unnatur
amidelink
oligom
encod
rna
also
design
express
screen
peptid
consist
unnatur
amino
acid
techniqu
peptid
librari
construct
constantli
evolv
care
sidebysid
comparison
necessari
determin
best
design
may
actual
specif
individu
display
platform
recent
approv
number
peptid
clinic
purpos
reflect
recognit
promis
therapeut
agent
molecul
natur
involv
immun
recognit
heavili
exploit
display
technolog
two
basic
type
immunolog
interact
includ
bind
antibodi
antigen
ii
bind
cell
receptor
tcr
major
histocompat
complex
mhc
present
antigenderiv
peptid
structur
divers
antibodi
tcr
turn
suitabl
platform
construct
display
librari
sourc
specif
function
antigentarget
molecul
parallel
construct
mhc
platformdisplay
librari
initi
facilit
detect
immun
recognit
mediat
tcr
technolog
may
futur
applic
target
medicin
antibodi
librariespres
autoantibodi
variou
antigen
reveal
infect
also
autoimmun
allerg
diseas
cancer
factor
induc
autoantibodi
selfantigen
usual
includ
protein
mutat
overexpress
aberr
modif
cell
local
serolog
identif
antigen
recombin
express
clone
term
serex
involv
bacteri
express
cdna
librari
deriv
tumor
tissu
screen
recombin
protein
autolog
serum
pioneer
combinatori
search
tumor
antigen
list
diseas
antigen
humor
immun
respons
detect
continu
grow
review
elsewher
sever
antibodi
approv
us
food
drug
administr
fda
use
therapeut
clinic
sever
year
emerg
target
anticanc
therapi
angiogenesi
process
vasculatur
sprout
exist
blood
vessel
regul
vascular
endotheli
growth
factor
vegf
receptor
recent
exampl
antibodi
clinic
anticanc
activ
vegfr
pathway
fda
approv
avastin
bevacizumab
antivegf
human
monoclon
antibodi
breakthrough
treatment
variou
cancer
target
tumorrel
angiogenesi
drugconjug
antibodi
direct
cancer
antigen
includ
rituxan
zevalin
nonhodgkin
lymphoma
herceptin
metastat
breast
cancer
mylotarg
acut
myeloid
leukemia
campath
alemtuzumab
bcell
chronic
lymphocyt
leukemia
cll
erbitux
cetuximab
antiegfr
advanc
colorect
cancer
among
mani
other
despit
recent
develop
approach
streamlin
gener
antibodi
human
tradit
techniqu
rais
antibodi
desir
activ
specif
remain
pose
limit
screen
antibodi
librari
aim
isol
prototyp
drug
target
cancer
diseas
one
main
approach
target
discoveri
valid
display
technolog
instrument
explor
humor
immun
respons
antibodi
immunogeneicitybas
signatur
cancer
system
profil
interestingli
screen
combinatori
antibodi
librari
cancer
patient
immunoglobulin
identifi
metastat
tumor
cell
indic
tumor
induc
antibodi
potenti
therapi
target
integrin
group
identifi
stressrespons
chaperon
cancer
antigen
induc
humor
immun
respons
variou
display
platform
vector
util
display
antibodi
sever
differ
format
origin
librari
immunoglobulin
fragment
fab
singl
chain
antibodi
scfv
display
filament
phage
design
recombin
antibodi
engin
remain
dynam
field
new
approach
construct
librari
antibodylik
molecul
display
antigen
recognit
motif
develop
exampl
librari
display
variabl
domain
camelid
heavi
chain
antibodi
domain
select
antagonist
antiegfr
nanobodi
effici
inhibit
egf
bind
egfr
egfmedi
signal
delay
growth
tumor
xenograft
affibodi
backbon
base
one
iggbind
domain
staphylococc
proteina
random
creat
librari
select
cancer
epitop
tnfalpha
creat
agent
potenti
use
imag
therapi
target
applic
addit
dissect
immun
respons
tumor
antibodi
display
librari
recent
use
wide
varieti
applic
rang
proteasom
character
age
map
immun
respons
infect
recent
scfv
phage
display
librari
use
screen
vasculatur
proofofconcept
select
perform
lumin
endotheli
cell
plasma
membran
isol
tissu
enrich
protein
expos
bloodstream
vivo
home
select
antibodi
confirm
wholebodi
imag
display
technolog
acceler
translat
antibodi
target
therapeut
one
fdaapprov
antibodi
gener
use
phage
display
adalimumab
humira
human
antitnf
use
rheumatoid
arthriti
mani
antibodi
select
phage
display
clinic
trial
exampl
includ
anti
sever
leukaemia
asthma
antitgf
idiopath
pulmonari
fibrosi
muscular
dystrophi
cellderiv
autoimmun
diseas
well
antitumor
necrosi
factor
relat
apoptosisinduc
ligand
receptor
variou
cancer
recent
antibodi
block
immunosuppress
molecul
identifi
pan
phagedisplay
antibodi
librari
deriv
rabbit
immun
primari
chronic
lymphocyt
leukemia
cll
cell
undoubtedli
phage
display
technolog
great
potenti
proteomewid
explor
humor
immun
respons
product
therapeut
antibodi
tcr
librariesprogress
understand
process
antigen
present
recognit
tcr
express
antigenspecif
cell
led
identif
sever
diseasespecif
self
antigen
present
mhc
class
mhci
dendrit
cell
dc
elicit
antigenspecif
cytotox
lymphocyt
ctl
elimin
virusinfect
mutat
cell
among
antigen
myeloid
leukemiaassoci
deriv
serin
proteas
proteinas
neutrophil
elastas
wilm
tumor
antigen
overexpress
sever
tumor
includ
myeloid
lymphoid
leukemia
diseasespecif
ctl
stimul
vitro
prime
antigenpres
cell
apc
puls
peptid
antigen
vivo
vaccin
peptid
howev
limit
number
mhci
present
diseasespecif
antigen
peptid
identifi
far
contrast
tradit
hypothesisdriven
investig
display
strategi
potenti
high
throughput
discoveri
diseasespecif
mhcpeptid
counterpart
tcr
first
approach
tcr
display
librari
creat
use
singlechain
variabl
domain
human
tcr
vivo
cytotox
lymphocyt
use
tcell
receptor
recogn
cell
abnorm
antigen
present
activ
antigenspecif
cell
kill
specif
tcr
recognit
toward
mhcpresent
antigen
alter
cell
make
candid
cellspecif
drug
deliveri
altern
tcr
introduc
patient
cell
use
call
passiv
immun
tcr
consist
alpha
beta
chain
chain
contain
variabl
v
domain
constant
c
domain
similar
immunoglobulin
fv
vdomain
tcr
contain
hypervari
region
determin
specif
cell
structur
antigenrecogn
site
tcr
similar
antibodi
similar
antibodi
recombin
tcr
express
bacteria
singlechain
tcr
sctcr
without
loss
specif
antigen
sever
group
achiev
sctcr
express
display
format
made
first
step
toward
select
peptidespecif
tcr
tcr
librari
howev
due
low
affin
bind
tcr
mhcipeptid
modif
sctcr
like
multimer
mutat
necessari
sensit
detect
target
mhcipeptid
yeast
surfac
display
tcr
also
shown
possibl
express
sctcr
permut
variabl
region
residu
proxim
domain
yeast
surfac
anoth
feasibl
strategi
select
antibodi
mhcpeptid
complex
tcrlike
antibodi
immun
antibodi
librari
use
approach
number
mhcpeptid
antibodi
therapeut
diagnost
potenti
obtain
exampl
krogsgaard
et
al
use
antibodi
isol
immun
phage
display
librari
visual
myelin
basic
protein
mbp
cell
epitop
multipl
sclerosi
lesion
other
use
phage
displayselect
fab
fragment
mhc
class
irestrict
specif
fuse
signal
molecul
retarget
primari
human
lymphocyt
usag
tcrlike
antibodi
molecul
studi
mhci
antigen
present
health
diseas
well
therapeut
purpos
cancer
infecti
diseas
autoimmun
disord
recent
review
elsewher
mhcpeptid
librariestcr
normal
recogn
antigen
process
proteasom
present
grove
mhci
mhcii
molecul
linear
peptid
display
random
peptid
librari
context
mhc
purpos
patient
tcell
repertoir
surveil
would
enabl
high
throughput
identif
mhcrestrict
peptid
target
cellspecif
therapi
vivo
interact
mhcpeptid
tcr
take
place
context
apc
tcell
orchestr
group
support
cell
surfac
molecul
interact
among
other
challeng
mimic
supramolecular
structur
context
display
system
addit
mhcpeptid
librari
construct
screen
hamper
mhc
present
must
accompani
noncoval
bound
macroglobulin
therefor
express
fold
function
activ
complex
e
coli
periplasm
technic
difficult
final
natur
low
affin
tcr
bind
complex
particular
absenc
stimul
molecul
mediat
effici
immunolog
synaps
make
select
display
librari
complex
nevertheless
possibl
express
complex
display
filament
phage
demonstr
studi
fold
singl
chain
fusion
achiev
evidenc
specif
recognit
relev
conformationspecif
monoclon
antibodi
importantli
uniqu
tcrlike
ie
peptidespecif
mhcirestrict
antibodi
unfortun
author
could
demonstr
interact
display
fold
singl
chain
mhcpeptid
complex
cell
consist
low
affin
tcr
bind
mhcpeptid
increas
avid
achiev
tetramer
mhcpeptid
complex
allow
visual
interact
attempt
design
multival
display
mhcpresent
antigen
le
doussal
et
al
demonstr
bival
fusion
peptidemhci
present
small
fraction
phage
particl
even
low
ratio
bival
phage
bind
k
display
phage
restrict
tcr
immobil
solid
phase
well
k
restrict
tcell
hybridoma
shown
still
signific
bind
relev
cell
detect
studi
therefor
optim
peptidemhc
display
still
await
tcrmediat
immun
recognit
becom
subject
product
screen
ctl
antigen
correspond
tcr
use
display
technolog
display
method
gener
limit
term
length
polypeptid
translat
librari
clone
shorter
fragment
natur
select
advantag
librari
unit
encod
need
less
time
product
less
like
pose
constraint
display
unit
function
issu
relev
virusphag
display
method
see
section
longer
polypeptid
higher
chanc
disrupt
virion
function
assembl
infect
addit
major
phage
display
system
protein
gener
express
ctermin
fusion
nterminu
minor
coat
protein
piii
display
phage
particl
fulllength
cdna
gener
contain
sever
stop
codon
near
end
approach
use
express
phage
surfac
problem
imped
progress
construct
use
fulllength
cdna
librari
display
applic
instead
initi
breakthrough
achiev
librari
display
protein
fragment
protein
domain
librari
develop
antibodi
epitop
map
directli
unequivoc
identifi
antigen
given
advantag
techniqu
approach
wide
use
serv
screen
whole
yeast
proteom
protein
domain
bind
second
srchomolog
domain
protein
certain
case
howev
direct
display
whole
protein
proven
feasibl
plasminogenactiv
inhibitor
among
first
display
piii
protein
filament
phage
phagedisplay
retain
capac
form
equimolar
complex
target
serin
proteas
tissuetyp
plasminogen
activ
tpa
well
abil
inhibit
tpa
activ
procedur
display
clone
cdna
evolv
significantli
sinc
monoval
phage
display
reli
helper
phage
see
section
made
whole
protein
present
gener
possibl
consider
technic
advanc
systemat
express
cdna
librari
surfac
bacteriophag
achiev
develop
junfo
fusion
approach
system
adopt
vitro
select
catalyt
activ
polypeptid
interest
attempt
undertaken
screen
extracellular
protein
use
cdna
librari
protein
carri
cell
membran
local
domain
display
filament
phage
anoth
perspect
approach
may
evolv
tool
isol
seminatur
molecul
potenti
superior
short
peptid
antibodi
base
display
avim
multidomain
polypeptid
shuffl
extracellular
domain
receptor
studi
avim
multival
display
phage
select
librari
result
isol
avim
high
avid
result
subnanomolar
affin
addit
widespread
usag
immunolog
molecul
immunoglobulin
tcr
natur
design
display
permut
polypeptid
sequenc
mani
novel
librari
framework
may
adopt
present
polypeptid
display
librari
applic
cell
surfac
protein
polypeptid
present
scaffold
discuss
correspond
section
bacteri
yeast
mammalian
cell
surfac
display
see
section
nonconvent
scaffold
protein
display
discuss
excel
recent
review
key
select
librari
platform
avail
expos
loop
link
stabl
structur
element
alphahelic
betasheet
loop
access
ligand
bind
accommod
sequenc
variat
without
chang
overal
structur
stabil
underli
scaffold
tertiari
structur
rigid
scaffold
modul
presenc
stabil
disulfid
bond
link
spatial
separ
strand
protein
base
architectur
backbon
scaffold
protein
classifi
consist
alphahelic
ii
secondari
structur
irregular
architectur
alphahelic
betasheet
iii
predominantli
betasheet
exampl
scaffold
alphahel
framework
includ
zdomain
affibodi
immun
protein
e
coli
cytochrom
ankyrin
repeat
protein
other
exampl
scaffold
irregular
structur
includ
kunitz
domain
protein
pdz
domain
protein
exampl
scaffold
betasheet
framework
includ
tcr
ctla
protein
knottin
fibronectin
typeiii
domain
function
protein
also
evolv
attract
scaffold
polypeptid
display
exampl
betabarrel
green
fluoresc
protein
gfp
serv
combinatori
peptid
librari
display
scaffold
peptid
exhibit
antiprolif
effect
select
anoth
use
function
protein
execut
seri
small
domain
term
protein
transduct
domain
ptd
tat
protein
herp
simplex
viru
protein
third
alphahelix
antennapedia
homeodomain
penetratin
promot
intracellular
transport
peptid
protein
across
cell
membran
cell
select
cell
membran
permeabl
librari
ptddisplay
polypeptid
could
becom
approach
identif
molecul
cell
local
andor
function
interest
label
peptid
optic
imag
nuclear
scintigraphi
magnet
reson
imag
could
biolog
medic
applic
principl
underli
display
technolog
abil
physic
link
phenotyp
polypeptid
display
certain
platform
correspond
genotyp
first
shown
phage
display
typic
phenotyp
regist
display
assay
physic
bing
serial
select
although
link
polypeptid
encod
dna
extend
function
select
method
yeast
twohybrid
system
assay
intracellular
interact
convent
consid
separ
categori
display
scaffold
present
polypeptid
librari
vari
abil
link
individu
polypeptid
select
base
particular
properti
code
nucleic
acid
cdna
mrna
featur
make
possibl
identifi
isol
amplifi
desir
librari
member
five
major
display
technolog
evolv
parallel
fig
elabor
individu
display
method
special
emphasi
filament
phage
display
sinc
major
interest
group
techniqu
origin
develop
map
epitopebind
site
antibodi
pan
random
peptidephag
librari
immobil
immunoglobulin
sinc
phage
display
use
power
method
regist
polypeptid
bind
divers
rang
basic
biolog
well
technic
medic
applic
biolog
phage
well
review
contrast
lytic
bacteriophag
speci
eg
filament
phage
replic
assembl
without
kill
escherichia
coli
host
abund
capsid
compon
major
coat
protein
pviii
repres
approxim
molecul
molecul
minor
piii
coat
protein
one
end
phage
virion
along
copi
pvi
anoth
minor
coat
protein
involv
bacteri
cell
bind
termin
phage
particl
assembl
morphogenesi
end
phage
cap
five
complex
minor
coat
protein
pvii
pix
requir
initi
mainten
phage
assembl
host
bacteria
librari
use
commonli
polypeptid
display
express
fusion
phage
coat
protein
piii
phage
assembl
process
result
fusion
protein
transport
bacteri
periplasm
inner
cell
membran
incorpor
phage
particl
along
singlestrand
dna
ssdna
encod
display
fusion
protein
thu
phage
clone
produc
host
e
coli
peptid
phenotyp
coupl
genotyp
two
basic
format
polypeptid
display
phage
librari
polyval
monoval
polyval
phage
display
copi
capsid
protein
piii
display
polypeptid
librari
type
base
vector
deriv
directli
phage
genom
fd
phage
encod
protein
need
phage
replic
assembl
polyval
phage
display
commonli
use
select
librari
short
peptid
display
interfer
essenti
function
piii
protein
monoval
phage
display
solut
cdna
librari
encod
protein
protein
domain
larg
piii
protein
retain
function
monoval
display
particl
mosaic
recombin
wildtyp
capsid
protein
produc
phagemid
vector
encod
fusion
protein
helper
phage
respect
purpos
helper
phage
provid
protein
requir
phagemid
replic
ssdna
product
packag
henc
allow
phage
rescu
big
advantag
phage
display
account
widespread
use
conveni
librari
select
targetspecif
binder
rapid
enrich
librari
clone
encod
bind
polypeptid
achiev
phage
librari
incub
target
follow
remov
nonreact
phage
amplif
binder
clone
host
bacteria
usual
three
five
round
pan
suffici
enrich
bind
peptid
sequenc
primari
structur
polypeptid
correspond
clone
deduc
sequenc
correspond
encod
dna
manner
librari
larg
divers
approxim
uniqu
individu
sequenc
creat
amplifi
store
screen
target
interest
phage
display
normal
enabl
isol
targetspecif
polypeptid
affin
constant
micromolartonanomolar
rang
gener
multival
phage
display
sensit
due
compar
higher
avid
result
multipl
copi
peptid
display
henc
detect
loweraffin
bind
necessari
affin
matur
individu
clone
perform
gener
secondari
librari
mutat
peptid
phage
display
coat
protein
piiialthough
piii
protein
far
commonli
use
phage
display
altern
display
system
util
four
coat
protein
pviii
pvi
pvii
pix
also
test
stand
asid
protein
display
system
pviiibas
platform
featur
mani
copi
coat
protein
per
particl
may
offer
specif
advantag
imag
applic
recent
multival
display
system
altern
piii
filament
phage
pvii
minor
coat
protein
report
author
show
pvii
protein
appar
structur
compromis
fusion
larg
polypeptid
scfv
antibodi
fragment
thu
demonstr
feasibl
util
pvii
fusion
partner
without
necess
coinfect
helper
phage
requir
piii
phagemid
system
slow
steadi
progress
design
phagemid
vector
allow
effici
display
correctli
fold
function
protein
phage
new
system
constantli
ad
applic
involv
specif
type
display
protein
use
display
variou
type
librari
system
repres
limit
one
attempt
display
protein
fold
properli
periplasm
filament
phage
assembl
cytoplasm
membran
secret
infect
bacteria
without
cell
lysi
correct
transfer
hybrid
capsid
protein
across
lipid
bilay
inner
membran
e
coli
prevent
overcom
limit
altern
bacteriophag
display
system
assembl
capsid
cytoplasm
releas
via
cell
lysi
develop
use
lytic
bacteriophag
librari
peptid
display
lytic
phage
speci
also
creat
screen
select
cdna
librari
novagen
often
use
isol
interact
protein
recent
epitom
approach
global
antibodyantigen
interact
map
develop
base
phage
display
cdna
librari
bacteriophag
lambda
yet
anoth
altern
vector
surfac
display
peptid
protein
featur
make
lambda
phage
potenti
advantag
abil
display
multimer
protein
lack
display
fusion
secret
requir
adjust
valenc
display
fusion
lambda
display
suggest
altern
poorli
solubl
protein
tend
form
inclus
bodi
express
bacteria
lambdabas
system
potenti
attract
protein
display
cdna
librari
input
function
proteom
progress
like
increas
follow
use
system
sinc
origin
incept
perhap
suggest
gener
applic
lambda
phagedisplay
librari
routin
use
screen
peptid
antibodi
librari
ligand
purifi
immobil
molecul
vitro
numer
research
group
employ
phage
display
select
peptid
bind
purifi
protein
interest
project
aim
identif
proteinprotein
interact
pair
map
interact
domain
recent
exampl
group
includ
select
random
peptid
bind
sparc
integrin
caspas
metalloproteas
exploit
agent
direct
drug
deliveri
exampl
peptid
antibodi
identifi
screen
prospect
drug
target
review
elsewher
sever
recent
develop
phage
display
applic
proteinprotein
interact
map
worth
note
select
infect
phage
technolog
sip
implement
systemat
registr
proteinprotein
interact
attempt
map
proteinligand
interact
use
whole
genom
phage
librari
underway
predict
identif
protein
interact
use
phage
display
highthroughput
like
complement
synerg
largescal
initi
aim
similar
goal
anoth
exampl
interactometyp
research
screen
membran
voltagedepend
anionselect
channel
protein
vdac
epitop
use
phage
librari
express
liver
cdna
vdac
reconstitut
liposom
captur
chip
surfac
remark
least
hit
alreadi
report
voltagedepend
anion
channel
vdac
ligand
novel
interact
function
block
channel
success
identif
peptid
epitop
set
basi
subsequ
util
phage
display
map
protein
interact
domain
kolonin
et
al
unpublish
past
decad
approach
effici
select
phage
librari
cultur
cell
evolv
one
method
enabl
quick
effect
isol
specif
ligand
small
number
cell
biopan
rapid
analysi
select
interact
ligand
brasil
establish
group
recent
exampl
success
phage
display
select
cell
includ
identif
peptid
target
vascular
endotheli
cell
gastric
cancer
vegfmim
shown
phage
particl
display
ligand
bind
intern
receptor
integrin
undergo
effici
uptak
target
cell
shown
case
peptid
antibodi
display
base
notion
phage
display
technolog
success
mobil
target
gene
deliveri
mammalian
cell
encourag
success
librari
select
complex
biolog
system
surfac
cell
investig
pursu
clinic
util
phage
display
ex
vivo
protocol
select
evalu
librari
biopsi
specimen
develop
recent
report
procedur
tumor
cell
suspens
deriv
biopsi
specimen
seven
human
breast
tumor
follow
librari
subtract
normal
breast
tissu
subject
select
result
peptid
target
phosphatidylserin
bind
annexin
v
apoptosi
identifi
goal
develop
new
tool
apoptosi
imag
past
decad
pioneer
number
novel
phage
display
applic
subsequ
research
group
combin
random
peptid
librari
select
platform
strategi
compris
advanc
molecular
biolog
bioinformat
well
util
clinicallyannot
patient
sampl
approach
allow
quickli
effici
identifi
function
cell
surfac
receptor
conjunct
ligand
directli
use
prototyp
therapeut
target
exampl
peptid
target
tumor
receptor
identifi
function
explor
use
preclin
studi
expand
sever
exampl
recent
develop
illustr
systemat
strategi
appli
clinic
cell
surfac
proteom
map
human
tumor
vascular
bed
one
featur
tumor
vasculatur
fenestr
make
tumor
cell
directli
access
circul
mani
cancer
present
proteom
tumor
cell
potenti
directli
target
system
administ
therapeut
advanc
construct
cell
surfac
ligandreceptor
map
human
cancer
panel
human
cancer
cell
line
differ
histolog
origin
grade
recent
systemat
analyz
phage
display
use
brasil
select
peptid
bind
receptor
express
cell
combinatori
librari
select
peptid
survey
use
comprehens
strategi
figur
statist
analysi
peptid
motif
sequenc
cell
line
assign
uniqu
set
peptid
motif
isol
select
cell
surfac
binder
show
tumor
cell
group
profil
phage
displayderiv
peptid
ligand
direct
differenti
express
cell
surfac
receptor
dissect
cancer
cell
surfac
proteom
approach
peptidetarget
receptor
identif
design
analysi
select
peptid
motif
sequenc
group
cell
line
accord
profil
motif
distribut
within
peptid
motif
found
within
protein
known
bind
receptor
express
profil
match
cell
line
recognit
profil
peptid
implic
cancer
candid
target
cell
surfac
molecul
identifi
includ
mani
tyrosin
kinas
receptor
proof
principl
epiderm
growth
factor
receptor
egfr
known
upregul
variou
cancer
valid
target
pool
tripeptid
isol
candid
mimic
biolog
egfr
ligand
result
feasibl
studi
suggest
tumor
cell
group
profil
peptid
ligand
direct
differenti
express
cell
surfac
receptor
approach
select
phagedisplay
peptid
home
receptor
differenti
access
vasculatur
specif
organ
vivo
phage
display
select
perform
without
preconceiv
notion
target
receptor
ident
identifi
phagedisplay
ligand
peptid
home
organ
interest
unbias
intern
control
process
procedur
involv
intraven
administr
phagedisplay
random
peptid
librari
let
circul
certain
period
time
allow
distribut
clone
vascular
system
fig
follow
perfus
possibl
andor
necessari
wash
tissu
cell
remov
nonspecif
bound
phage
clone
clone
home
select
vascular
bed
recov
host
e
coli
infect
amplifi
subsequ
round
select
vivo
phage
display
two
main
applic
first
librari
select
use
approach
identifi
ligand
target
specif
vascular
bed
second
determin
molecular
profil
blood
vessel
specif
diseas
enabl
identif
differenti
express
diseas
marker
complementari
approach
use
identifi
receptor
peptid
home
vasculatur
lung
breast
placenta
white
adipos
tissu
organ
anim
model
also
use
identifi
tumorvascular
molecular
address
phage
display
systemat
implement
strategi
eventu
lead
complet
map
vascular
ligandreceptor
interact
vivo
select
anim
model
variou
peptid
librari
screen
ligand
select
home
tissu
mice
includ
brain
kidney
lung
skin
pancrea
intestin
uteru
adren
gland
retina
lymph
node
muscl
prostat
breast
placenta
white
adipos
tissu
strategi
also
uncov
vascular
address
system
allow
angiogenesisrel
target
tumor
blood
vessel
mous
pancreat
cancer
model
use
profil
progress
tumor
benign
metastat
state
phagedisplay
peptid
past
year
anim
model
altern
mice
exploit
includ
rat
insect
approach
combin
vivo
select
novel
random
peptid
librari
ex
vivo
bacteri
twohybrid
hybrid
use
identifi
candid
heart
endotheli
receptor
possibl
limit
evalu
crossspeci
conserv
home
pattern
vasculartarget
peptid
underlin
need
design
approach
directli
profil
vasculatur
human
case
data
home
ligand
receptor
gener
anim
model
use
valid
correspond
drug
target
human
diseas
howev
becom
clear
inform
deriv
studi
mice
alway
easili
translat
real
clinic
applic
speciesspecif
differ
express
mani
vascular
target
inconsist
recapitul
result
murin
model
human
biolog
may
correl
frequent
lack
immedi
success
translat
clinic
trial
uncov
crossspeci
variat
express
present
tumor
marker
psma
serv
exampl
could
perhap
account
lack
efficaci
mere
differ
tissu
site
level
time
express
vascular
protein
mice
men
may
partial
explain
prodrug
identifi
use
mice
undergo
unexpect
local
human
therefor
inappropri
liganddirect
target
thu
vivo
phage
display
data
deriv
anim
model
must
care
valid
appli
clinic
studi
reason
vivo
select
phage
display
random
peptid
librari
directli
patient
would
repres
major
advanc
identif
clinic
relev
vascular
target
probe
facilit
develop
target
deliveri
agent
human
vasculatur
initi
step
select
phagedisplay
random
peptid
librari
analyz
peptid
motif
distribut
bone
marrow
prostat
fat
muscl
skin
cancer
patient
perform
high
throughput
analysi
motif
recov
five
organ
bone
marrow
white
fat
skelet
muscl
prostat
skin
organ
identifi
frequent
isol
short
tripeptid
motif
could
direct
bind
blood
vessel
upon
phage
librari
intraven
administr
contain
within
select
peptid
largescal
survey
almost
tripeptid
show
distribut
combinatori
peptid
human
tissu
nonrandom
organhom
tripeptid
enrich
singl
organ
wherea
other
enrich
multipl
organ
consist
work
hypothesi
bind
tissuespecif
endotheli
marker
other
bind
ubiquit
vascular
cell
surfac
molecul
identifi
candid
protein
mimick
organhom
motif
search
protein
databas
sequenc
share
among
multipl
select
peptid
highthroughput
analysi
motif
similar
reveal
differenti
express
cell
surfac
protein
valid
demonstr
approach
identifi
function
ligandreceptor
pair
show
motif
grragg
mimic
interleukin
il
show
peptid
bind
receptor
larg
followup
studi
wellannot
archiv
human
tissu
reveal
express
increas
prostat
cancer
associ
vasculatur
particular
upon
prostat
cancer
metastasi
also
evalu
target
primari
metastat
prostat
cancer
use
morpholog
function
analys
importantli
although
recogn
target
human
cancer
specif
requir
ligandreceptor
bind
molecular
mechan
enabl
signal
transduct
well
understood
base
phage
display
select
data
design
valid
intandem
strategi
bind
assay
sitedirect
mutagenesi
nmr
spectroscopi
show
grragg
sequenc
mimic
new
function
proteinbind
site
within
et
al
submit
singl
select
round
larg
uniqu
peptid
sequenc
phage
librari
usual
suffici
enrich
organhom
peptid
vivo
phage
display
screen
encompass
recoveri
phage
organ
interest
threetofour
round
librari
select
util
one
subject
per
round
thu
systemat
character
vasculatur
use
convent
vivo
setup
ratelimit
need
separ
perform
individu
multiround
screen
motif
home
tissu
studi
instanc
report
patient
screen
involv
singl
round
select
therefor
requir
statist
analysi
larg
number
phage
clone
thousand
oppos
hundr
convent
screen
identifi
home
peptid
motif
systemat
vascular
map
also
practic
limit
number
phage
clone
routin
process
thu
requir
methodolog
optim
order
meet
challeng
recent
introduc
comprehens
strategi
use
phage
display
synchron
identif
organhom
peptid
multipl
tissu
screen
simultan
strategi
allow
one
survey
order
magnitud
fewer
peptid
sequenc
analyz
origin
method
due
statist
power
gener
subsequ
select
round
fig
evalu
approach
mice
perform
screen
isol
peptid
independ
segreg
six
differ
organ
develop
statist
analysi
platform
identif
motif
select
enrich
target
tissu
final
demonstr
effici
approach
biochem
valid
one
identifi
pancreashom
peptid
mimic
peptid
hormon
bind
prolactin
receptor
improv
statist
algorithm
analyz
peptid
sequenc
isol
serial
synchron
select
use
bayesian
mixtur
model
complex
highdimension
count
data
current
develop
ji
et
al
press
unpreced
initi
screen
combinatori
librari
cancer
patient
repres
major
step
toward
ultim
goal
outlin
molecular
map
human
vasculatur
ethic
guidelin
provid
framework
patientori
research
endoflif
cancer
patient
establish
screen
librari
directli
patient
acceler
develop
drug
target
protein
differenti
express
activ
vasculatur
associ
human
tumor
diseas
serial
synchron
approach
vivo
librari
select
outlin
practic
direct
continu
human
vascular
map
initi
current
use
identifi
valid
tissuespecif
molecular
address
cancer
patient
kolonin
et
al
unpublish
phage
display
develop
biotechnologyappl
phage
display
surfac
late
reflect
potenti
phage
display
technolog
repres
exampl
integr
phage
display
advanc
biotechniqu
use
realtim
polymeras
chain
reaction
pcr
facilit
identif
celland
tissuespecif
peptid
quantit
pcr
allow
quantifi
number
librari
clone
bound
cell
interest
demonstr
select
live
cell
formalinfix
paraffinembed
tissu
section
realtim
pcr
also
adopt
monitor
chang
phage
bind
cardiac
vascular
epitop
upon
age
method
potenti
clinic
diagnost
phage
displaymedi
immunopcr
pdipcr
modif
immunopcr
ipcr
perform
recombin
phage
particl
instead
monoclon
antibodi
pdipcr
phagedisplay
scfv
encod
phage
dna
combin
detect
templat
unit
sensit
assay
achiev
convent
enzymelink
immunosorb
assay
elisa
anoth
recent
illustr
progress
result
coevolv
technolog
combin
phage
display
laser
captur
microdissect
lcm
use
isol
cell
specif
origin
section
complex
heterogen
tissu
biopsi
autopsi
recoveri
phage
bind
cell
interest
success
assist
lcm
mice
vivo
librari
administr
well
ex
vivo
applic
phage
freshli
collect
oral
squamou
cell
carcinoma
also
fluorochrom
label
phage
display
librari
introduc
method
studi
bind
specif
well
phage
display
applic
flow
cytometri
fluoresc
microscopi
combin
enzymat
assay
phage
display
technolog
use
identif
peptid
function
properti
interest
enzym
substrat
similar
approach
undertaken
identif
peptid
inhibitori
properti
instanc
random
peptid
librari
use
sourc
pseudomona
aeruginosa
murd
amid
ligas
inhibitor
thu
provid
prototyp
compound
target
cell
wall
biosynthesi
pathogen
anoth
studi
antiprotect
antigen
peptid
select
phage
librari
competit
pan
lethal
factor
precursor
anthrax
toxin
select
peptid
synthes
tetrabranch
form
modifi
inhibitori
efficaci
prototyp
artifici
antianthrax
protect
antigen
similarli
enzymat
activ
kallikrein
serin
proteas
may
mediat
metastasi
prostat
cancer
subject
combinatori
select
phage
librari
sever
select
peptid
valid
inhibitor
activ
therefor
prototyp
drug
prostat
cancer
anoth
approach
phage
display
librari
base
bind
rxp
motif
use
identifi
novel
peptid
sequenc
bind
modifi
regul
moreov
phage
display
use
function
target
specif
cell
compart
nonprotein
natur
exampl
peptid
librari
select
peptid
bind
liposom
phdepend
manner
abl
caus
leakag
liposom
content
lipo
polysaccharid
also
recent
explor
target
peptid
display
phage
librari
phage
display
recent
use
identifi
adhes
molecul
express
microbi
pathogen
mediat
infect
et
al
use
peptid
librari
identifi
interact
tat
envelop
glycoprotein
enhanc
viru
attach
entri
cell
well
map
interact
site
tat
anoth
studi
screen
phagedisplay
librari
identifi
combinatori
peptid
bind
surfac
aspergillu
fumigatu
conidia
hypha
variou
comput
tool
algorithm
gener
facilit
predict
protein
interact
site
base
phage
display
bind
data
combin
phagedisplay
random
peptid
librari
select
comput
predict
instanc
allow
map
neutral
antibodi
epitop
spike
protein
sever
acut
respiratori
syndrom
sar
coronaviru
well
defin
cellular
coronaviru
receptor
thu
approach
develop
sar
inhibitor
provid
phage
long
use
antibacteri
agent
preantibiot
era
recent
fda
approv
bacteriophag
prepar
food
addit
readytoeat
meat
poultri
product
vehicl
base
phage
may
ultim
proven
particularli
use
treatment
infecti
diseas
display
bacteriaor
fungustarget
moieti
phage
surfac
improv
deliveri
cytotox
payload
pathogen
applic
phagedisplay
random
peptid
librari
identif
motif
facilit
transport
across
gastrointestin
mucos
barrier
well
transderm
transport
intact
skin
may
also
acceler
translat
phagebas
technolog
imag
therapi
among
excit
novel
applic
phage
display
base
combin
emerg
field
nanotechnolog
possibl
use
phagedisplay
peptid
antibodi
highthroughput
microarray
format
also
explor
altogeth
phage
display
technolog
like
remain
instrument
identif
valid
priorit
ligand
molecular
target
express
cell
surfac
well
peptid
drug
lead
direct
target
among
effici
mammalian
vector
cell
transduct
gene
therapi
purpos
initi
modul
retrovir
host
rang
success
experi
incorpor
antibodi
antibodyrecogn
epitop
envelop
protein
perform
retrovir
particl
express
target
envelop
show
advanc
cell
infect
small
librari
contain
lamininbind
human
synthet
scfv
display
retroviru
also
recent
gener
select
result
mark
enrich
antigen
binder
singl
select
cycl
baculoviru
also
develop
display
platform
interestingli
viru
infect
insect
cell
present
librari
peptid
discuss
see
section
peptid
present
major
histocompat
complex
mhci
mhcii
display
baculoviru
recogn
tcr
present
pathogen
epitop
capsidlik
particl
hepat
b
viru
result
enhanc
immunogen
also
report
baculoviru
envelop
modif
display
technolog
also
perform
direct
viral
tropism
tumor
cell
tumorhom
peptid
origin
identifi
vivo
phage
display
display
baculovir
surfac
fuse
transmembran
anchor
vesicular
stomat
viru
g
protein
target
virion
specif
bound
intern
human
tumor
cell
display
tumortarget
ligand
appear
enhanc
baculovirusmedi
gene
deliveri
adenoassoci
viru
aav
advantag
virus
abil
select
integr
mammalian
genom
specif
region
thu
lack
pathogen
relat
genom
disrupt
insert
mutagenesi
direct
aav
cell
interest
target
adaptor
peptid
conjug
adenovirusbind
moieti
well
incorpor
tumortarget
peptid
recombin
aav
capsid
direct
viru
tropism
success
proofofconcept
aavbas
librari
display
random
peptid
design
screen
human
coronari
arteri
endotheli
cell
select
peptid
motif
enhanc
transduct
coronari
endotheli
cell
control
cell
confirm
aav
viabl
target
vehicl
recent
aav
also
test
vivo
display
applic
peptid
identifi
base
home
rat
lung
brain
incorpor
region
capsid
result
virus
display
peptid
virion
surfac
retarget
transgenecarri
virus
expect
vascular
bed
vivo
recent
first
time
group
also
report
deliveri
report
therapeut
gene
vivo
use
hybrid
vector
genet
sicel
merg
deriv
bacteriophag
adenoassoci
viru
term
new
doublestrand
aavsinglestrand
bacteriophag
vector
aav
phage
aavp
aavp
carri
transgen
cassett
intracellular
convers
singl
strand
doubl
strand
dna
target
integrinexpress
cell
enabl
tumor
transduct
molecular
genet
imag
tumor
model
adenoviru
one
gener
accept
platform
gene
deliveri
lag
behind
viral
platform
term
provid
system
direct
librari
display
select
howev
attempt
modifi
adenovir
capsid
protein
broaden
adenoviru
tropism
insert
target
moieti
underway
may
eventu
identifi
viral
surfac
protein
site
use
librari
peptid
display
combin
advanc
optim
assay
assess
quantifi
gene
transfer
acceler
clinic
implement
virusdirect
gene
therapi
dna
express
libraryencod
polypeptid
fusion
extracellular
receptor
fig
select
bacteri
express
librari
scfv
antibodi
introduc
use
periplasm
express
cytometr
screen
pec
technolog
approach
periplasm
local
librari
protein
serv
dialysi
bag
select
retain
scfvbound
free
ligand
fluoresc
label
ligand
allow
one
perform
cytometr
screen
cell
contain
antibodyantigen
complex
sinc
abil
display
polypeptid
interest
fusion
protein
bacteri
envelop
also
test
potenti
altern
viralphag
display
bacteri
display
also
serv
display
function
enzym
vaccin
antigen
polypeptid
librari
outer
membran
protein
gramneg
bacteria
use
carrier
protein
present
foreign
peptid
epitop
bacteri
cell
surfac
foreign
gene
product
fuse
surfaceaccess
region
porin
outer
membran
protein
ompa
ompc
phoe
lamb
fhua
btub
insert
amino
acid
residu
toler
certain
case
anoth
class
bacteri
surfac
protein
display
autotransport
contain
transloc
domain
mediat
outer
membran
traffick
passeng
replac
natur
passeng
domain
autotransport
heterolog
protein
lead
display
bacteri
surfac
transloc
domain
surfac
display
human
cathepsin
g
inhibitor
indic
bacteri
peptid
librari
subject
function
screen
base
target
enzym
label
despit
proofofprincipl
experi
sidebysid
comparison
bacteri
phage
display
peptid
librari
search
targetbind
motif
indic
phagebas
platform
may
advantag
shown
display
cell
wall
yeast
saccharomyc
cerevisia
possibl
cell
surfac
glycoprotein
mediat
interact
mate
typespecif
agglutin
yeast
display
provid
advantag
bacteriabas
technolog
case
cellsurfac
secret
protein
requir
endoplasm
reticulumspecif
posttransl
process
effici
fold
activ
date
yeast
display
allow
present
numer
function
protein
cell
surfac
exampl
heterooligomer
fab
fragment
catalyt
antibodi
express
tandemlink
ctermin
half
conjunct
express
secret
fd
fragment
heavi
chain
combin
fab
fragment
assambl
yeast
cell
surfac
catalyz
hydrolysi
correspond
substrat
addit
antibodi
yeast
display
also
develop
express
cell
receptor
subsequ
studi
holler
et
al
screen
yeast
display
librari
valpha
mutant
higher
affin
solubl
monomer
tcr
variant
select
tcr
variant
affin
low
nanomolar
rang
advantag
wildtyp
tcr
highaffin
tcr
capabl
directli
detect
peptidemhc
complex
antigenpres
cell
recent
jin
et
al
appli
yeast
display
molecular
evolut
human
integrin
protein
egf
result
protein
mutant
remark
affin
physiolog
interactor
identifi
mammalian
cell
displayalthough
highli
effici
microbi
display
technolog
limit
protein
fold
posttransl
modif
differ
codon
usag
mammal
establish
approach
display
design
peptid
interest
surfac
mammalian
cell
provid
opportun
high
throughput
analysi
interact
peptid
protein
correctli
fold
modifi
import
breakthrough
mammalian
display
technolog
achiev
singlechain
fv
express
cell
surfac
display
cell
prove
principl
affin
matur
possibl
mammalian
system
cell
express
antibodi
high
affin
effici
enrich
larg
excess
cell
express
lower
affin
antibodi
moreov
select
combinatori
librari
random
intrins
antibodi
hotspot
also
success
although
approach
challeng
inher
limit
librari
manag
mammalian
cell
develop
target
system
becom
relev
biomed
applic
vitro
display
system
may
overcom
limit
cumbersom
cellbas
display
method
major
potenti
advantag
size
librari
display
therefor
divers
subject
select
cellfre
assay
transform
step
limit
librari
divers
decad
sinc
incept
vitro
display
librari
screen
specif
highaffin
targetbind
molecul
includ
peptid
antibodi
fragment
whole
function
protein
present
variou
scaffold
ribosom
displayribosom
polysom
display
among
first
cellfre
vitro
display
assay
develop
ribosom
display
select
base
ternari
complex
form
result
vitro
translat
protein
attach
ribosom
encod
mrna
stabil
mrnaribosomepolypeptid
complex
rabbit
reticulocyt
translat
system
achiev
modul
magnesium
ion
concentr
termin
polypeptid
elong
either
chloramphenicol
low
temperatur
fig
immobil
mrna
amplifi
polysom
complex
bound
target
round
select
ribosom
display
proven
valuabl
method
select
high
affin
compound
divers
librari
applic
ribosom
display
biomark
identif
imag
target
like
evolv
exampl
ribosom
display
use
select
dnabind
protein
three
differ
zinc
finger
dnabind
protein
librari
contain
random
sequenc
finger
select
biotinyl
target
dna
fragment
bound
streptavidin
magnet
bead
lead
isol
semisynthet
factor
potenti
novel
transcript
activ
ribosomallydisplay
combinatori
librari
ankyrin
repeat
protein
darpin
select
binder
mapkinas
remark
singl
round
ribosom
display
select
lead
isol
specif
bind
ligand
micromolar
affin
subsequ
select
enrich
darpin
nanomolar
affin
confirm
function
cellular
cytoplasm
moreov
shown
affin
matur
phage
antibodi
popul
use
ribosom
display
gener
high
antibodi
k
picomolar
rang
without
use
error
prone
mutagenesi
wherea
highest
affin
antibodi
scfv
fragment
produc
phage
display
k
nanomolar
rang
improv
cellfre
translat
system
achiev
combin
recombin
e
coli
protein
factor
purifi
ribosom
higher
selectionspecif
cdna
yield
observ
attempt
prevent
dissoci
tripartit
rnaribosomepolypeptid
complex
may
improv
robust
system
may
make
ribosom
display
userfriendli
method
combinatori
select
complex
polypeptid
encod
mrna
gener
vitro
translat
synthet
mrna
carri
puromycin
peptidyl
acceptor
antibiot
end
vitro
translat
ribosom
reach
junction
mrna
engin
dna
linker
stall
allow
puromycin
entri
ribosom
asit
format
stabl
amid
bond
encod
peptid
fig
proofofprincipl
fusion
mrna
molecul
encod
myc
epitop
peptid
enrich
pool
random
sequenc
mrnapeptid
fusion
immunoprecipit
continu
effort
use
mrna
display
isol
highaffin
ligand
variou
combinatori
semicombinatori
random
trypsin
inhibitor
eetiii
peptid
librari
select
enrich
bind
motif
unidirect
nest
delet
librari
display
mrna
use
map
epitop
antipolyhistidin
monoclon
antibodi
lead
isol
highaffin
polyhistidin
peptid
confirm
viabil
approach
addit
mrna
display
librari
facilit
design
combinatori
librari
encod
peptid
synthes
unnatur
amino
acid
nonbiolog
polym
may
potenti
farreach
advantag
due
extend
spectra
bind
target
biolog
stabil
howev
gener
applic
technolog
remain
determin
time
coval
dna
displaycoval
display
technolog
cdt
exploit
unusu
properti
replic
initi
protein
e
coli
bacteriophag
replic
attach
protein
dna
endonucleas
initi
roll
circl
replic
process
bind
viral
origin
ori
introduc
singlestrand
discontinu
nick
dna
prime
dna
synthesi
use
host
replic
machineri
final
attach
molecul
dna
express
still
poorli
understood
cisact
featur
enabl
pool
polypeptid
link
synthes
vitro
also
becom
coval
attach
code
dna
fig
potenti
capabl
avoid
mani
problem
limit
display
system
ctd
yet
underutil
recent
howev
reiersen
et
al
report
suitabl
ctd
librari
select
coval
antibodi
display
cad
use
specif
select
antitetanu
toxoid
scfv
vgene
librari
million
differ
member
prepar
human
lymphocyt
although
vulner
dna
rna
complex
fundament
vitro
display
method
may
pose
problem
futur
vitro
display
technolog
could
becom
instrument
direct
evolut
protein
also
vivo
select
applic
current
limit
phage
display
futur
display
technolog
larg
depend
improv
screen
approach
vector
librari
construct
optim
display
scaffold
technic
advanc
method
streamlin
display
assay
see
section
may
refin
effici
strategi
select
ligand
interest
display
librari
result
variou
display
librari
screen
indic
mani
case
select
peptid
motif
target
receptor
via
mimick
biolog
ligand
receptor
analysi
peptid
motif
target
individu
receptor
provid
basi
ration
drug
design
target
peptidomimet
current
undertaken
base
liganddirect
map
interact
map
vivo
phage
display
follow
human
vascular
map
effort
investig
new
drug
ind
studi
plan
three
peptidomimet
drug
group
cancer
obes
advanc
tool
peptid
structur
analysi
open
new
possibl
rapid
effici
identif
valid
receptor
target
peptid
contextdirect
function
screen
exampl
giordano
et
al
use
nmr
spectroscopi
understand
structur
basi
interact
vegfmim
mimic
peptid
vegf
receptor
led
identif
three
key
residu
involv
ligandreceptor
bind
ration
antiangiogenesi
drug
design
base
inform
current
develop
giordano
et
al
unpublish
integr
display
technolog
nanotechnolog
emerg
field
target
nanoparticl
pursu
multifunct
entiti
divers
biomed
applic
combin
display
technolog
highthroughput
screen
approach
like
greatli
advanc
rate
inform
gener
similarli
way
achiev
genom
project
final
develop
silico
bioinformat
system
biolog
tool
manag
threedimension
informationintens
data
come
display
select
also
underway
combin
effort
becom
major
drive
forc
continu
applic
display
technolog
need
clinic
proteom
drug
discoveri
schema
avail
display
technolog
display
platform
base
abil
physic
link
polypeptid
produc
librari
clone
correspond
genotyp
allow
one
recov
dna
encod
clone
select
base
desir
polypeptid
phenotyp
bind
target
phageviru
display
linkag
gene
encod
polypeptid
achiev
express
polypeptid
fusion
coat
protein
dna
packag
particl
cell
display
linkag
gene
encod
polypeptid
achiev
express
polypeptid
fusion
cell
surfac
molecul
dna
cell
receiv
order
transform
ribosom
display
linkag
gene
encod
polypeptid
achiev
stabil
complex
ribosom
mrna
encod
polypeptid
upon
termin
elong
permiss
marker
chloramphenicol
low
temperatur
mrna
display
linkag
gene
encod
polypeptid
achiev
puromycin
molecul
coval
bond
mrna
translat
polypeptid
upon
ribosom
stall
junction
mrna
engin
singlestrand
dna
linker
coval
dna
display
linkag
gene
encod
polypeptid
achiev
coval
bond
form
dnabind
protein
produc
fusion
polypeptid
dna
encod
fusion
figur
depict
scale
comprehens
strategi
systemat
character
ligandreceptor
proteom
function
surfac
cancer
cell
line
use
ligandmimick
peptid
isol
combinatori
phage
display
librari
identif
cell
surfac
receptor
solubl
ligand
enrich
receptor
like
target
mean
liganddirect
schema
vivo
display
librari
select
librari
display
polypeptid
intraven
inject
anim
let
circul
allow
bind
polypeptid
differenti
express
receptor
blood
vessel
perfus
remov
unbound
librari
bound
ligand
elut
extract
tissu
librari
clone
encod
ligand
amplifi
inject
anim
subsequ
round
vivo
select
scheme
strategi
serial
synchron
vivo
display
librari
select
everi
select
round
librari
clone
intraven
administ
bound
peptid
simultan
recov
n
target
tissu
amplifi
pool
use
next
select
round
round
recoveri
frequenc
compar
tissuehom
peptid
black
line
nonspecif
control
peptid
background
color
line
progress
increas
frequenc
peptid
everi
subsequ
round
select
reflect
enrich
peptid
preferenti
home
target
organ
